US Stock MarketDetailed Quotes
TNXP Tonix Pharmaceuticals
- 0.1897
- +0.0014+0.74%
Close Nov 29 13:00 ET
- 0.1899
- +0.0002+0.11%
Post 16:59 ET
35.45MMarket Cap-2P/E (TTM)
0.2097High0.1884Low29.00MVolume0.1906Open0.1883Pre Close5.72MTurnover15.52%Turnover Ratio0.00P/E (Static)186.89MShares22.137652wk High0.48P/B35.45MFloat Cap0.118052wk Low--Dividend TTM186.89MShs Float263679868.1600Historical High--Div YieldTTM11.31%Amplitude0.1180Historical Low0.1970Avg Price1Lot Size
Tonix Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 308.35%28.23M | -83.78%4.16M | -90.21%7.05M | -79.25%24.95M | -79.25%24.95M | -95.06%6.91M | -82.39%25.62M | -48.75%71.98M | -32.71%120.23M | -32.71%120.23M |
| -Cash and cash equivalents | 308.35%28.23M | -83.78%4.16M | -90.21%7.05M | -79.25%24.95M | -79.25%24.95M | -95.06%6.91M | -82.39%25.62M | -48.75%71.98M | -32.71%120.23M | -32.71%120.23M |
| Receivables | 538.92%9.98M | --3.34M | ---- | -24.12%6.1M | -24.12%6.1M | --1.56M | ---- | ---- | 4.10%8.04M | 4.10%8.04M |
| -Accounts receivable | 156.91%4.01M | --3.34M | ---- | ---- | ---- | --1.56M | ---- | ---- | ---- | ---- |
| -Accrued interest receivable | --523K | ---- | ---- | --1.51M | --1.51M | ---- | ---- | ---- | --0 | --0 |
| -Other receivables | --5.44M | ---- | ---- | -42.93%4.59M | -42.93%4.59M | ---- | ---- | ---- | 4.10%8.04M | 4.10%8.04M |
| Inventory | -37.90%8.27M | -30.97%9.46M | --12.35M | --14.15M | --14.15M | --13.32M | --13.7M | ---- | --0 | --0 |
| Other current assets | -57.46%4.06M | -30.61%8.34M | -8.96%10.7M | 2.59%2.57M | 2.59%2.57M | -14.49%9.54M | -18.67%12.01M | -6.40%11.75M | -5.93%2.51M | -5.93%2.51M |
| Total current assets | 61.29%50.54M | -50.74%25.29M | -64.05%30.1M | -63.47%47.77M | -63.47%47.77M | -79.27%31.34M | -73.23%51.33M | -45.27%83.73M | -30.82%130.78M | -30.82%130.78M |
| Non current assets | ||||||||||
| Net PPE | -54.79%43.38M | -54.67%43.94M | -1.22%93.82M | 0.34%94.85M | 0.34%94.85M | 5.27%95.95M | 15.34%96.93M | 35.01%94.98M | 83.65%94.53M | 83.65%94.53M |
| -Gross PPE | -53.19%46.98M | -53.16%47.03M | 2.69%100.15M | 4.19%100.21M | 4.19%100.21M | 9.11%100.34M | 18.67%100.4M | 37.72%97.52M | 85.42%96.18M | 85.42%96.18M |
| -Accumulated depreciation | 18.09%-3.6M | 10.87%-3.09M | -148.78%-6.33M | -224.38%-5.36M | -224.38%-5.36M | -437.94%-4.4M | -513.63%-3.47M | -449.89%-2.55M | -313.25%-1.65M | -313.25%-1.65M |
| Goodwill and other intangible assets | -98.90%120K | -98.93%120K | --10.47M | 8,823.33%10.71M | 8,823.33%10.71M | --10.95M | --11.19M | ---- | --120K | --120K |
| -Goodwill | --0 | --0 | --965K | --965K | --965K | --965K | --965K | ---- | --0 | --0 |
| -Other intangible assets | -98.80%120K | -98.83%120K | --9.51M | 8,019.17%9.74M | 8,019.17%9.74M | --9.98M | --10.22M | ---- | --120K | --120K |
| Other non current assets | -9.51%951K | 229.11%961K | 149.35%960K | 327.65%1.13M | 327.65%1.13M | 191.94%1.05M | -22.96%292K | 1.58%385K | -30.34%264K | -30.34%264K |
| Total non current assets | -58.83%44.45M | -58.47%45.02M | 10.36%105.25M | 12.41%106.69M | 12.41%106.69M | 17.96%107.95M | 28.42%108.41M | 34.83%95.36M | 83.05%94.91M | 83.05%94.91M |
| Total assets | -31.80%94.99M | -55.99%70.31M | -24.43%135.34M | -31.56%154.46M | -31.56%154.46M | -42.60%139.28M | -42.16%159.74M | -19.95%179.09M | -6.31%225.69M | -6.31%225.69M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -49.54%3.94M | 35.62%10.41M | -17.05%6.65M | -53.12%3.78M | -53.12%3.78M | 71.18%7.8M | -19.81%7.67M | -14.70%8.02M | -39.26%8.07M | -39.26%8.07M |
| -accounts payable | -49.54%3.94M | 35.62%10.41M | -17.05%6.65M | -53.12%3.78M | -53.12%3.78M | 71.18%7.8M | -19.81%7.67M | -14.70%8.02M | -39.26%8.07M | -39.26%8.07M |
| Current accrued expenses | -14.20%8.15M | -17.35%8.54M | 132.37%10.73M | 86.13%5.14M | 86.13%5.14M | 14.73%9.5M | 77.24%10.33M | -16.92%4.62M | 23.03%2.76M | 23.03%2.76M |
| Current debt and capital lease obligation | 613.13%3.1M | 610.32%3.1M | 607.08%3.1M | 506.48%2.62M | 506.48%2.62M | -13.89%434K | -14.68%436K | 10.33%438K | -11.66%432K | -11.66%432K |
| -Current capital lease obligation | -36.64%275K | -36.47%277K | -36.76%277K | -37.50%270K | -37.50%270K | -13.89%434K | -14.68%436K | 10.33%438K | -11.66%432K | -11.66%432K |
| Current deferred liabilities | ---- | ---- | ---- | -8.95%2.98M | -8.95%2.98M | ---- | ---- | ---- | 15.57%3.27M | 15.57%3.27M |
| Current liabilities | -14.39%15.18M | 19.53%22.04M | 56.65%20.48M | 3.87%18.88M | 3.87%18.88M | 32.93%17.73M | 15.92%18.44M | -14.86%13.07M | -16.28%18.18M | -16.28%18.18M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | 681.70%5.6M | 641.40%6.16M | 1,043.03%6.72M | 2,092.99%7.19M | 2,092.99%7.19M | 87.43%716K | 75.32%831K | 45.19%588K | -29.76%328K | -29.76%328K |
| -Long term debt | --5.17M | --5.67M | --6.16M | --6.56M | --6.56M | ---- | ---- | ---- | ---- | ---- |
| -Long term capital lease obligation | -40.64%425K | -40.67%493K | -4.25%563K | 92.68%632K | 92.68%632K | 87.43%716K | 75.32%831K | 45.19%588K | -29.76%328K | -29.76%328K |
| Derivative product liabilities | --0 | --0 | --0 | --22.86M | --22.86M | ---- | ---- | ---- | --0 | --0 |
| Total non current liabilities | 681.70%5.6M | 641.40%6.16M | 1,043.03%6.72M | 9,060.98%30.05M | 9,060.98%30.05M | 87.43%716K | 75.32%831K | 45.19%588K | -29.76%328K | -29.76%328K |
| Total liabilities | 12.62%20.78M | 46.34%28.2M | 99.11%27.2M | 164.38%48.93M | 164.38%48.93M | 34.45%18.45M | 17.64%19.27M | -13.31%13.66M | -16.57%18.51M | -16.57%18.51M |
| Shareholders'equity | ||||||||||
| Share capital | 766.67%156K | -9.09%10K | 15.63%74K | 391.67%59K | 391.67%59K | -66.04%18K | -99.97%11K | -88.43%64K | -25.00%12K | -25.00%12K |
| -common stock | 766.67%156K | -9.09%10K | 15.63%74K | 391.67%59K | 391.67%59K | -66.04%18K | -65.63%11K | -88.43%64K | -25.00%12K | -25.00%12K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -23.59%-708.59M | -27.32%-694.37M | -19.07%-615.6M | -27.79%-600.66M | -27.79%-600.66M | -30.79%-573.34M | -33.22%-545.36M | -33.85%-516.99M | -30.63%-470.04M | -30.63%-470.04M |
| Paid-in capital | 12.75%782.89M | 7.39%736.71M | 6.06%723.91M | 4.28%706.36M | 4.28%706.36M | 4.04%694.37M | 7.57%686.03M | 14.96%682.57M | 17.07%677.38M | 17.07%677.38M |
| Gains losses not affecting retained earnings | -13.64%-250K | -14.62%-243K | -13.74%-240K | -38.92%-232K | -38.92%-232K | -37.50%-220K | -48.25%-212K | -78.81%-211K | -81.52%-167K | -81.52%-167K |
| Total stockholders'equity | -38.58%74.21M | -70.03%42.1M | -34.63%108.14M | -49.07%105.53M | -49.07%105.53M | -47.22%120.83M | -45.93%140.46M | -20.45%165.43M | -5.27%207.18M | -5.27%207.18M |
| Total equity | -38.58%74.21M | -70.03%42.1M | -34.63%108.14M | -49.07%105.53M | -49.07%105.53M | -47.22%120.83M | -45.93%140.46M | -20.45%165.43M | -5.27%207.18M | -5.27%207.18M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
